Previous 10 | Next 10 |
2023-05-28 09:15:00 ET With savvy stock-picking and a bit of patience, building wealth isn't as difficult as it is often made out to be. This is because quality businesses grow their revenue and profits, which makes their shares more valuable over time. Shares of AstraZeneca (NASD...
2023-05-26 13:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-26 09:28:04 ET A committee of the European Medicines Agency (EMA) recommended revoking the marketing authorization of Novartis' ( NYSE: NVS ) Adakveo, which is used to preventing painful crises (called vaso-occlusive crises) in patients aged 16 years and older with sick...
2023-05-26 08:30:43 ET Palm Beach, FL – May 26, 2023 – FinancialNewsMedia.com News Commentary – Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from the breast. It is a...
2023-05-26 06:38:37 ET Elon Musk's brain-implant company Neuralink said in a tweet that it received approval from the U.S. Food and Drug Administration to conduct human clinical trials of the device. "This is the result of incredible work by the Neuralink team in close collaboration wit...
2023-05-25 19:36:30 ET Summary It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS could generate sales of $6.3 billion by 2030. Roche Holding AG reported positive results reported from ...
2023-05-25 18:00:00 ET Summary High dividend yield companies can help you earn an extra income in the form of dividends, which you can then use to cover your expenses. In this article, I will introduce you to 10 companies that I believe are attractive picks for investors since the...
2023-05-24 11:02:18 ET Summary Agios Pharmaceuticals, Inc. has done well after its pivot to rare diseases. The move has also generated a huge amount of cash. Their SCD trial go/no-go decision will be very important. I have been covering Agios Pharmaceuticals, Inc. ...
2023-05-24 07:20:00 ET Summary The debt ceiling crisis is coming down to the wire. We're possibly already out of time to prevent default and just don't know it. UBS estimates a short default could create a 20% bear market and a one-month default could lead to a 44% crash. Even...
2023-05-24 06:33:55 ET U.K.-based Advanz Pharma signed an agreement to get exclusive rights from Alvotech ( NASDAQ: ALVO ) to commercialize five proposed biosimilars in Europe. Alvotech said it will be responsible for development and commercial supply while Advanz will be...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...